line
March 11, 2015 Categories: Clinical

ERT Expands Scientific Consulting Group

Industry Veteran Brings 30 Years of COA Experience to Scientific and Regulatory Team

February 26, 2015 Categories: Clinical, Healthcare

ERT to Acquire PHT Corporation

Combined Company Will Offer Comprehensive Patient-Centric Collection and Analytics Platforms for Global Clinical Trials

February 2, 2015 Categories: Clinical, Healthcare

ERT’s AVERT to be used by Rutgers University Behavioral Health Care in NJ High Schools and Universities

Suicide Risk Assessment System to Identify and Enable Treatment for At-Risk Students

January 26, 2015 Categories: Clinical, Healthcare

ERT Supports Improved Healthcare Delivery in Low-Resource Areas

ECG Device Donations Enable Effective Cardiac Health Monitoring throughout Haiti

January 8, 2015 Categories: Clinical, Healthcare

ERT Maintains Top Level of Drug Approval Support

PHILADELPHIA – January 8, 2014 –– ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced that for the second consecutive year, over 50% of the compounds approved by U.S. FDA have utilized the use of ERT’s cardiac safety, respiratory, and/or electronic Clinical Outcome Assessment (eCOA) solutions to capture critical safety and/or efficacy data during clinical development.  The approvals were granted to biopharmaceutical companies in 2013 and 2014.

December 16, 2014 Categories: Clinical

PPD and ERT Establish Strategic Partnership to Enhance Drug Development

Agreement expands innovative data collection offerings for biopharmaceutical clients

November 6, 2014 Categories: Clinical, Healthcare

ERT Announces Acquisition of eClinical Insights

Combined Offering Enables Real Time Decision Making in Global Clinical Trials

October 27, 2014 Categories: Clinical, Healthcare

ERT Named Innovation Award Recipient by Philadelphia Business Journal

Company Recognized for Advancements in Patient Safety

October 13, 2014 Categories: Clinical, Healthcare

ERT Announces Updates to Executive Management Team

Ron Sullivan joins Experienced Leadership Team as Executive Vice President and Product Line Executive for eCOA

October 9, 2014 Categories: Clinical

ERT’s Scientific and Regulatory Consultants Support Phase III Oncology Trial

Provectus Biopharmaceuticals Collaborates with ERT’s COA Experts to Understand Patient Perspective during Melanoma Drug Development

1 2 3 4 512